184 related articles for article (PubMed ID: 22483700)
1. Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.
Brooks JD; Boice JD; Stovall M; Reiner AS; Bernstein L; John EM; Lynch CF; Mellemkjær L; Knight JA; Thomas DC; Haile RW; Smith SA; Capanu M; Bernstein JL; Shore RE;
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):917-24. PubMed ID: 22483700
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study.
Brooks JD; Boice JD; Shore RE; Reiner AS; Smith SA; Bernstein L; Knight JA; Lynch CF; John EM; Malone KE; Mellemkjaer L; Langballe R; Liang X; Woods M; Tischkowitz M; Concannon P; Stram DO;
Breast; 2020 Dec; 54():62-69. PubMed ID: 32927238
[TBL] [Abstract][Full Text] [Related]
3. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
[TBL] [Abstract][Full Text] [Related]
4. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
5. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.
Brooks JD; John EM; Mellemkjaer L; Lynch CF; Knight JA; Malone KE; Reiner AS; Bernstein L; Liang X; Shore RE; Stovall M; ; Bernstein JL
Cancer Med; 2016 Nov; 5(11):3282-3291. PubMed ID: 27700016
[TBL] [Abstract][Full Text] [Related]
6. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW;
Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288
[TBL] [Abstract][Full Text] [Related]
7. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
Stovall M; Smith SA; Langholz BM; Boice JD; Shore RE; Andersson M; Buchholz TA; Capanu M; Bernstein L; Lynch CF; Malone KE; Anton-Culver H; Haile RW; Rosenstein BS; Reiner AS; Thomas DC; Bernstein JL;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1021-30. PubMed ID: 18556141
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.
Knight JA; Fan J; Malone KE; John EM; Lynch CF; Langballe R; Bernstein L; Shore RE; Brooks JD; Reiner AS; Woods M; Liang X; Bernstein JL;
Int J Cancer; 2017 Sep; 141(5):916-924. PubMed ID: 28524234
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
10. Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.
Sisti JS; Bernstein JL; Lynch CF; Reiner AS; Mellemkjaer L; Brooks JD; Knight JA; Bernstein L; Malone KE; Woods M; Liang X; John EM;
Springerplus; 2015; 4():825. PubMed ID: 26751177
[TBL] [Abstract][Full Text] [Related]
11. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Brooks JD; Teraoka SN; Reiner AS; Satagopan JM; Bernstein L; Thomas DC; Capanu M; Stovall M; Smith SA; Wei S; Shore RE; Boice JD; Lynch CF; Mellemkjaer L; Malone KE; Liang X; ; Haile RW; Concannon P; Bernstein JL
Hum Mutat; 2012 Jan; 33(1):158-64. PubMed ID: 21898661
[TBL] [Abstract][Full Text] [Related]
12. The impact of lifestyle and reproductive factors on the risk of a second new primary cancer in the contralateral breast: a systematic review and meta-analysis.
Akdeniz D; Klaver MM; Smith CZA; Koppert LB; Hooning MJ
Cancer Causes Control; 2020 May; 31(5):403-416. PubMed ID: 32130573
[TBL] [Abstract][Full Text] [Related]
13. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy and risk of contralateral breast cancer.
Storm HH; Andersson M; Boice JD; Blettner M; Stovall M; Mouridsen HT; Dombernowsky P; Rose C; Jacobsen A; Pedersen M
J Natl Cancer Inst; 1992 Aug; 84(16):1245-50. PubMed ID: 1640483
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and risk of second primary breast cancer: the WECARE Study.
Brooks JD; John EM; Mellemkjær L; Reiner AS; Malone KE; Lynch CF; Figueiredo JC; Haile RW; Shore RE; ; Bernstein JL; Bernstein L
Breast Cancer Res Treat; 2012 Jan; 131(2):571-80. PubMed ID: 21892703
[TBL] [Abstract][Full Text] [Related]
18. Smoking, Radiation Therapy, and Contralateral Breast Cancer Risk in Young Women.
Reiner AS; Watt GP; John EM; Lynch CF; Brooks JD; Mellemkjær L; Boice JD; Knight JA; Concannon P; Smith SA; Liang X; Woods M; Shore R; Malone KE; Bernstein L; ; Bernstein JL
J Natl Cancer Inst; 2022 Apr; 114(4):631-634. PubMed ID: 33779721
[TBL] [Abstract][Full Text] [Related]
19. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.
Reiner AS; John EM; Brooks JD; Lynch CF; Bernstein L; Mellemkjær L; Malone KE; Knight JA; Capanu M; Teraoka SN; Concannon P; Liang X; Figueiredo JC; Smith SA; Stovall M; Pike MC; Haile RW; Thomas DC; Begg CB; Bernstein JL
J Clin Oncol; 2013 Feb; 31(4):433-9. PubMed ID: 23269995
[TBL] [Abstract][Full Text] [Related]
20. Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER.
Neta G; Anderson WF; Gilbert E; Berrington A
Breast Cancer Res Treat; 2012 Feb; 131(3):1021-7. PubMed ID: 22015617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
